Publications by authors named "Kentaro Ikeya"

Claim this Profile
[
[Utility of abdominal ultrasonography in the management of ulcerative colitis:proposal of a new scoring system].
Shinsuke Sato, Kentaro Ikeya, Ryosuke Takano, Ai Matsuura, Yuji Ota

Nihon Shokakibyo Gakkai Zasshi· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease.
Masaichi Kato, Ken Sugimoto, Kentaro Ikeya, Ryosuke Takano, Ai Matsuura

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly Bioavailable Curcumin Derivative Ameliorates Crohn's Disease Symptoms: A Randomized, Double-Blind, Multicenter Study.
Ken Sugimoto, Kentaro Ikeya, Shigeki Bamba, Akira Andoh, Hiroshi Yamasaki

J Crohns Colitis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice.
Ken Sugimoto, Kentaro Ikeya, Masaichi Kato, Ai Matsuura, Fumitoshi Watanabe

Dig Dis· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.
Takayuki Yamamoto, Takayuki Iida, Kentaro Ikeya, Masaichi Kato, Ai Matsuura

Clin Transl Gastroenterol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.
Takayuki Yamamoto, Takayuki Iida, Kentaro Ikeya, Masaichi Kato, Ai Matsuura

Clin Transl Gastroenterol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
Yoichi Kakuta, Yosuke Kawai, Daisuke Okamoto, Tetsuya Takagawa, Kentaro Ikeya

J Gastroenterol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.
Takayuki Yamamoto, Takayuki Iida, Kentaro Ikeya, Masaichi Kato, Ai Matsuura

Clin Transl Gastroenterol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adsorptive Depletion of Myeloid Lineage Leucocytes as Remission Induction Therapy in Patients with Ulcerative Colitis after Failure of First-Line Medications: Results from a Three-Year Real World, Clinical Practice.
Takayuki Iida, Kentaro Ikeya, Masaichi Kato, Jinro Abe, Masayoshi Yamamoto

Digestion· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score.
Kentaro Ikeya, Hiroyuki Hanai, Ken Sugimoto, Satoshi Osawa, Shinsuke Kawasaki

J Crohns Colitis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
Ken Sugimoto, Kentaro Ikeya, Takayuki Iida, Shinsuke Kawasaki, Osamu Arai

Dig Dis Sci· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis.
Kentaro Ikeya, Ken Sugimoto, Shinsuke Kawasaki, Takayuki Iida, Yasuhiko Maruyama

Dig Liver Dis· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new paradigm in ulcerative colitis: regulatory T cells are key factor which induces/exacerbates UC through an immune imbalance.
Hiroyuki Hanai, Takayuki Iida, Kentaro Ikeya, Jinrou Abe, Yasuhiko Maruyama

Mol Immunol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Looking for endoscopic features of cytomegalovirus colitis: a study of 187 patients with active ulcerative colitis, positive and negative for cytomegalovirus.
Takayuki Iida, Kentaro Ikeya, Fumitoshi Watanabe, Jinro Abe, Yasuhiko Maruyama

Inflamm Bowel Dis· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A case of colonic obstruction due to post-operative stenosis of the colon and multiple enteroliths].
Akihiko Ohata, Fumitoshi Watanabe, Yasuhiko Maruyama, Masanobu Kageoka, Hirotaka Fumiiwa, Kentaro Ikeya

Nihon Shokakibyo Gakkai Zasshi· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis